He stated on Reddit that it was from a personal discussion with a J&J executive. I’m sure Merck and Pfizer executives own some RVVTF at this point too.
Dales used to work for Main Stream Financial Media at one point. He focuses on Pharmaceutical sector, but his statement didn’t move stock price.
I think it’s clear that everyone took it in stride, and in the manner it was provided….as a passing thought!
Johnson & Johnson makes tremendous sense as a buyer of Bucillamine.
1) weren’t able to cash in like Pfizer or Merck on vaccines
2) they have history of providing safe / proven drugs
3) would be supported by FDA as an old, established American Company
News 
Market Data 
Discover 
